BL-M07D1 binds HER2 (not topoisomerase I), is internalized, and releases a camptothecin-class payload that inhibits topoisomerase I to cause DNA damage and cell death; killing is restricted to HER2-targeted cells, not cells merely expressing topoisomerase I.